Skip to main content

Articles

Editorial
Thinking About 2030
David B. Nash, MD, MBA
Read More
Clinical, Original Research
Insights from Real-World Analysis of Treatment Patterns in Patients with Newly Diagnosed Knee Osteoarthritis
Stan Dysart, MD, MBA; Karina Utkina, PharmD; Laura Stong, PhD; Winnie Nelson, PharmD, MS, MBA; Naomi Sacks, PhD; Bridget Healey, MPH; Faizan Niazi, PharmD
Read More
Clinical, Original Research
Clinical Pharmacist Outreach to Increase Statin Use for Patients with Cardiovascular Disease in a Safety-Net Healthcare System
Paul Cornelison, PharmD; Joel C. Marrs, PharmD, MPH; Sarah L. Anderson, PharmD
Read More
Business, Original Research
Real-World Cost of Care for Commercially Insured versus Medicare Patients with Metastatic Pancreatic Cancer Who Received Guideline-Recommended Therapies
Samantha Tomicki, MPH; Gabriela Dieguez, FSA, MAAA; Helen Latimer, MPH; Paul Cockrum, PharmD; George Kim, MD
Read More
FDA Approvals, Select Drug Profiles
Jemperli First FDA-Approved Immunotherapy for Advanced Endometrial Cancer with dMMR Biomarker
Read More
FDA Approvals, Select Drug Profiles
Rybrevant First FDA-Approved Therapy for NSCLC with EGFR Exon 20 Insertion Mutations
Read More
FDA Approvals, Select Drug Profiles
Lumakras First FDA-Approved Therapy for Advanced or Metastatic NSCLC with KRAS G12C Mutation
Read More
FDA Approvals, Select Drug Profiles
Zynlonta First FDA-Approved CD19-Directed Therapy for Large B-Cell Lymphoma
Read More
Zanidatamab Shows Promising Activity in Patients with HER2-Overexpressing Gastric Cancers
Wayne Kuznar
Read More
Prostate Cancer
¹⁷⁷Lu-PSMA-617 Superior to Cabazitaxel in Metastatic Prostate Cancer
Phoebe Starr
Read More
Page 19 of 246
Results 181 - 190 of 2458